Should I Use Mounjaro? The Factors That Actually Matter

Does your BMI and health profile meet the licensed threshold?

The starting point is straightforward. The UK licence for Mounjaro covers adults with a BMI of 30 or above, or a BMI of 27 or above when at least one weight-related condition is present. Qualifying conditions include type 2 diabetes, high blood pressure, dyslipidaemia and obstructive sleep apnoea, among others. For some ethnic backgrounds (South Asian, Chinese, Middle Eastern, Black African and African-Caribbean) the threshold sits 2.5 kg/m² lower under UK clinical guidance, so the numbers shift accordingly.

Meeting the BMI threshold is necessary but not sufficient. A prescriber will also look at what else is in your medical history. Some conditions require extra care: a history of pancreatitis, certain gastrointestinal disorders, or a personal or family history of medullary thyroid carcinoma each need discussion. Pregnancy, breastfeeding, and trying to conceive are situations where Mounjaro is not recommended. Neither is it licensed for anyone under 18.

If you want to run your numbers before speaking to anyone, the NHS BMI calculator gives you a reliable starting point. Then the question moves on to the factors below.

Are you prepared for what treatment actually involves?

Mounjaro is a once-weekly subcutaneous injection using a pre-filled pen. Treatment starts at the 2.5mg dose, not because that amount does much therapeutically, but because starting low gives your system time to adjust before the dose is increased. Titration happens in steps, typically every four weeks, guided by your prescriber based on tolerability and response.

Side effects are real and worth factoring in. The most common are gastrointestinal: nausea, changes in bowel habit, indigestion, and fatigue, particularly in the first days after a dose change. For most people these settle. A smaller number find them persistent enough to influence the pace of titration. The NHS tirzepatide page lists the full side-effect profile in accessible terms and is worth reading before you start.

There is also the lifestyle element. Mounjaro works best alongside a reduced-calorie diet and increased physical activity, not as a replacement for them. People who get the most from it tend to be in a position to engage with both. That's not a moral point; it's a practical one about how the medicine is licensed and how the trial results were generated.

If you're weighing up the injection format against other options, our weight-loss treatments overview covers the landscape.

How does the cost and access picture affect your decision?

On the NHS, Mounjaro is becoming available to more people through a phased rollout, but the criteria are strict and supply through GP practices varies by area. Many people who are eligible in principle face waiting times, or fall just outside the current phase of commissioning. Understanding what private treatment costs and what that price includes is a reasonable part of the decision.

Private provision means no referral and no waiting list, but it does mean the cost falls to you directly. Eli Lilly raised Mounjaro's UK list price substantially from September 2025, and private prices since then have typically ranged from roughly £149 to £375 per month depending on dose and provider. What any legitimate price must include is a clinical assessment and a valid prescription, a prescriber is legally required before this medicine is dispensed.

At nume, one price covers the consultation, prescription, treatment, and free next-working-day tracked delivery. There are no subscriptions and no automatic renewals; every repeat order goes through a fresh clinical review. Worth checking whether that model suits you before committing to anything.

When is the answer probably no, at least for now?

There are situations where a prescriber will conclude that Mounjaro isn't the right choice at this point. Some are absolute: pregnancy, breastfeeding, under-18, certain thyroid cancer histories. Others are relative, meaning the prescriber weighs the benefit against the risk for your specific situation: severe kidney impairment, certain gastrointestinal conditions, or a history of eating disorders may each prompt a different route.

It's also worth thinking about timing. Treatment requires sustained engagement, regular injections, dose titration over months, lifestyle adjustments. If your circumstances make that difficult right now, starting and stopping is less effective than waiting until you can commit properly. Our guide to when stopping Mounjaro makes sense covers the exit question too, which is relevant when thinking about whether to begin.

For more on how tirzepatide works at a biological level, the tirzepatide overview goes into the mechanism in more depth. And if you want to understand the clinical thinking behind decisions like this, our clinical team page explains the prescriber review process at nume.

If, after working through this, you think the answer might be yes, the clearest next step is a consultation. Our prescribers review every assessment personally, the same day, and will tell you plainly whether treatment is appropriate for you. If you are still weighing up whether starting Mounjaro is the right move for you, that guide walks through the key considerations before you book. Similarly, if you are thinking through whether taking Mounjaro suits your health situation, or want a broader look at whether going on Mounjaro makes sense given your circumstances, both are worth reading alongside this page. Check your eligibility and start that conversation.